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Foreword by the EMCDDA 
 
This ‘quick guide’ version of the European drug prevention quality standards was prepared by 
Angelina Brotherhood and Harry R. Sumnall and was financed by the EMCDDA as part of its project: 
‘Preparation of IPA beneficiaries for their participation in the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA)’, Project No 2011/280–057, funded by the European Commission’s 
Instrument for Pre-Accession Assistance (IPA). It is based on an EMCDDA manual on the topic 
published in 2011. 
 
The aim of the guide is to make practical information on prevention quality standards available outside 
the European Union. It includes a description of the eight stages involved in the drug prevention cycle, 
along with a self-reflection checklist that can be used when planning and implementing prevention 
activities. It has been designed for practitioners and those working in the field. 
 
This product will be available online, initially in English and then in other languages, as the 
EMCDDA’s technical cooperation projects develop. 
 
We would like to take this opportunity to thank Angelina Brotherhood and Harry R. Sumnall for their 
contribution to the present publication. 
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Introduction 
 
About the quality standards 
 
The European drug prevention quality standards, published as Manual No 7 by the European 
Monitoring Centre on Drugs and Drug Addiction (EMCDDA) (
1
), provide the first European framework 
on how to conduct high quality drug prevention. The standards highlight the following aspects of 
quality in prevention work:  
 
 relevance of activities to target populations and (inter)governmental policies 
 adherence to accepted ethical principles 
 integration and promotion of the scientific evidence base, as well as 
 internal coherence, project feasibility and sustainability. 
 
The standards contained in the manual were developed during a two-year project with co-funding 
from the European Union under the Programme of Community Action in the field of Public Health 
(2003–08) (Project No 2007304). The project was carried out by the Prevention Standards 
Partnership, a multi-disciplinary and multi-sectoral collaboration of seven organisations across 
Europe, led by the Centre for Public Health at Liverpool John Moores University, UK (
2
). The 
EMCDDA supported the Partnership throughout the development process and has also funded the 
publication of the standards as a manual as well as the production of this quick guide. 
 
At the start of the project, guidance on how to plan and deliver effective drug prevention was available 
only in some Member States of the European Union (EU). Available guidance varied in terms of its 
quality, content and applicability, and a common European framework for quality in drug prevention 
was missing. Thus, the quality of drug prevention services would often rely upon the discretion of 
individual service providers and local authorities. The project therefore aimed to improve European 
drug prevention policy and practice by developing a common reference framework for drug prevention 
activities. 
 
To develop the standards, available European and international drug prevention guidance was 
collated and reviewed. At this stage, a distinction was made between guidance focussing on the 
content of interventions (the ‘what’) and guidance focussing on formal aspects of prevention work (the 
‘how’). The Partnership chose to focus on guidance on ‘how’ to do prevention (
3
). Nineteen sets of 
quality standards matching specific selection criteria were synthesised through qualitative content 
analysis to form a first draft. In the next stage, the relevance, usefulness, and feasibility of these draft 
standards was assessed through online surveys and focus groups in six EU countries. Over 400 
delegates from different professional groups gave feedback on the content of the draft standards and 
highlighted barriers to implementation. Based on these consultations, the Partnership revised and 
finalised the standards and produced the self-reflection checklist presented in this quick guide. 
Further information on the development of the standards can be found in the EMCDDA manual. 
 
Following completion of the project, the European drug prevention quality standards were also 
adapted to form the prevention strand in a study on the development of an EU Framework for 
minimum quality standards and benchmarks in drug demand reduction (EQUS) (
4
). 
 
                                                     
(
1
) Brotherhood,  A., Sumnall H., R. and the Prevention Standards Partnership (2011), European drug prevention quality 
standards: a manual for prevention professionals, EMCDDA Manuals No 7, Luxembourg. Publications Office of the European 
Union. 
(
2
) The partner organisations were: ASL di Milano (Italy), Consejeria de Sanidad – Servicio Gallego de Salud (Xunta de Galicia) 
(CS–SERGAS) (Spain), Azienda Sanitaria Locale n. 2 – Savonese (ASL2) (Italy), Institute for Social Policy and Labour – 
National Institute for Drug Prevention (SZMI-NDI) (Hungary), National Anti-Drug Agency (NAA) (Romania), and National 
Bureau for Drug Prevention (NBDP) (Poland). Please see the manual for names of individual contributors. 
(
3
) Standards focussing on ‘what’ to do in prevention have been published by the United Nations Office on Drugs and Crime 
(UNODC), see the International Standards on Drug Use Prevention at http://www.unodc.org/unodc/en/prevention/prevention-
standards.html  
(
4
) The EQUS project was led by the Research Institute for Public Health and Addiction at the University of Zurich and was also 
co-funded by the European Union. Further information can be found at http://www.isgf.ch/index.php?id=59&uid=41  
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The availability of an agreed framework that is adaptable to local circumstances should provide an 
incentive for EU Member States and other countries to develop quality standards where these did not 
previously exist (or to review and update existing quality standards), and to adopt these quality 
standards for their own use. Adoption of the standards will improve drug prevention practice and 
efficiency and effectiveness of commissioning, and reduce the likelihood of implementation of 
interventions with no or iatrogenic (i.e. negative) effects. Thus, the standards will support prevention 
professionals in the development and promotion of best practice, and will allow them to demonstrate 
success in reaching specific objectives of local, regional, national and international drug strategies 
and policies. 
 
The manual containing all standards is available for free from the EMCDDA: 
http://www.emcdda.europa.eu/publications/manuals/prevention-standards 
 
Find out more about the quality standards, contact the Prevention Standards Partnership and 
access supporting materials at: http://www.prevention-standards.eu  
 
 
The project cycle – three levels of detail 
 
Figure 1: The drug prevention project cycle 
 
 
The standards are organised chronologically in a project cycle. The project cycle was found to 
represent the best means of structuring the standards, based on the review of existing standards and 
the consultations with drug prevention professionals. 
 
The project cycle contains eight stages: needs assessment; resource assessment; programme 
formulation; intervention design; management and mobilisation of resources; delivery and monitoring; 
final evaluations; and dissemination and improvement. In addition, cross-cutting considerations in the 
centre of the project cycle highlight aspects which are relevant to every project stage, namely: 
sustainability and funding; communication and stakeholder involvement; staff development; and 
ethical drug prevention (see Figure 1).  
 
The cycle provides a template that professionals can adopt when planning and implementing 
prevention activities. However, it is also a simplified model of drug prevention work which 
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professionals should carefully adapt to the particular circumstances of their prevention work. For 
example, if an activity is already in the implementation phase, then the later project stages will be 
more relevant than the earlier project stages on programme planning.  
 
Each project stage is divided into several components which outline what actions to take. In total, 
there are 31 components across all project stages and 4 components within the cross-cutting 
considerations (see Table 1). In the manual, each component contains an introductory text which 
outlines why this component was included in the standards and what considerations should be taken 
into account during implementation. The numbering of components does not necessarily indicate 
priority or chronological order. 
 
Attributes constitute the third level within the standards, defining each component in greater detail. At 
this level, basic and expert standards are distinguished to account for the variety of prevention work 
and the different capacities of organisations. Only the basic standards are summarised in this 
document but all standards can be found in the full manual. 
  
European drug prevention quality standards: a quick guide 
 
 7 
Table 1: Project stages and components within the European drug prevention quality 
standards 
 
Cross-cutting Considerations 
 A: Sustainability and funding 
 B: Communication and stakeholder involvement 
 C: Staff development 
 D: Ethical drug prevention 
1. Needs assessment 
 1.1 Knowing drug-related policy and legislation 
 1.2 Assessing drug use and community needs 
 1.3 Describing the need – Justifying the intervention 
 1.4 Understanding the target population 
2. Resource assessment 
 2.1 Assessing target population and community resources 
 2.2 Assessing internal capacities 
3. Programme formulation 
 3.1 Defining the target population 
 3.2 Using a theoretical model 
 3.3 Defining aims, goals, and objectives 
 3.4 Defining the setting 
 3.5 Referring to evidence of effectiveness 
 3.6 Determining the timeline 
4. Intervention design 
 4.1 Designing for quality and effectiveness 
 4.2 If selecting an existing intervention 
 4.3 Tailoring the intervention to the target population 
 4.4 If planning final evaluations 
5. Management and mobilisation of resources 
 5.1 Planning the programme – Illustrating the project plan 
 5.2 Planning financial requirements 
 5.3 Setting up the team 
 5.4 Recruiting and retaining participants 
 5.5 Preparing programme materials 
 5.6 Providing a programme description 
6. Delivery and monitoring 
 6.1 If conducting a pilot intervention 
 6.2 Implementing the intervention 
 6.3 Monitoring the implementation 
 6.4 Adjusting the implementation 
7. Final evaluations 
 7.1 If conducting an outcome evaluation 
 7.2 If conducting a process evaluation 
8. Dissemination and improvement 
 8.1 Determining whether the programme should be sustained 
 8.2 Disseminating information about the programme 
8.3 If producing a final report 
 
 
Using the quality standards manual 
 
This quick guide is a summary of the quality standards manual which can be accessed via the 
website indicated in the box on page 5. In the manual, quality standards are understood as 
benchmarks that help prevention professionals judge whether an activity, a provider, etc. represents 
high quality. The standards manual encourages practitioners and other professionals working in the 
prevention field to think about how existing activities relate to the standards and how they can be 
improved using the standards in order to obtain (even) better and more sustainable results. 
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The manual provides detailed guidance on how the standards should and should not be used. Briefly, 
professionals will benefit the most from the standards manual if they use it: 
 
 for information, education and guidance (e.g. university courses, supervision)  
 for self-reflection or discussion in group settings (e.g. by practitioners who are in (direct) 
contact with the target population, by service managers or regional planning teams) 
 as a checklist during service development or evaluation (e.g. for programme developers, 
evaluators) 
 for developing or updating quality criteria (e.g. policymakers, funders)  
 for performance appraisals (e.g. to identify professional development needs). 
 
The standards are intended for a wide range of drug prevention activities (e.g. drug education, 
structured programmes, outreach work, brief interventions), settings (e.g. school, community, family, 
recreational settings, criminal justice), and target populations (e.g. young people, families, ethnic 
groups). Drug prevention activities targeted by these standards may focus on legal substances, such 
as alcohol or tobacco, and/or illegal substances.  
 
In recognition of this diversity within prevention work, the full standards offer two different levels: 
‘basic’ and ‘expert’. Basic standards should be applicable to all drug prevention work, regardless of its 
particular circumstances. Expert standards represent a higher level of quality; however, they may not 
always be applicable and users of the standards will have to determine whether they are relevant, 
useful and feasible with regard to the particular prevention activity. For simplicity, the present quick 
guide refers to the basic standards only. 
 
Although the focus of the standards is on interventions, they can also help professionals appreciate 
how people, organisations, policies and (governmental) strategies contribute to drug prevention. In 
fact, some standards can only be achieved by considering and improving the practical and strategic 
context within which interventions are embedded. For example, priorities and strategies set out by 
government and funding bodies must promote good practice in prevention.  
 
Based on the consultations undertaken to develop the standards, the manual is less appropriate for 
certain purposes. Using the quality standards cannot replace process and outcome evaluations. 
Although the standards can help achieve better evaluation results, evaluations are still required to 
understand whether and how interventions work. As presented in the manual, the standards are also 
less suitable for formal self-assessment, structured training, external accreditation or funding 
decisions. However, a follow-up project entitled ‘Promoting Excellence in Drug Prevention in the EU 
— Phase 2 of the European Drug Prevention Quality Standards Project’ is taking place from April 
2013 to March 2015 to make the standards more suitable for these particular purposes. It will also 
explore how the standards can improve prevention activities in the ‘real world’ and how achievement 
of the standards can be formally evidenced. As part of this follow-up project, examples of how the 
standards are being used in Europe and abroad, as well as toolkits to support standards 
implementation, will be published on www.prevention-standards.eu.  
 
 
Using this quick guide and the checklists  
 
This quick guide is aimed at: 
 
 professionals who are not yet familiar with the concept of quality standards in prevention and 
who wish to find out more about this topic 
 professionals who need more information about the standards in order to decide whether the 
manual could usefully support their work 
 professionals who wish to take a first step in conducting self-reflection using the standards. 
 
In terms of professional groups, policymakers and commissioners at national, regional and local 
levels as well as service managers will find this document particularly useful. 
 
Although the manual has already been translated into several languages (see the EMCDDA website 
for details), the present document is also intended to facilitate introduction of the standards in 
countries where translations of the full manual are not yet available.  
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This document does not replace the existing manual. Instead, this quick guide summarises the 
content of the manual and encourages professionals to start using the standards for self-reflection. 
Several important differences between the manual and this quick guide exist. Most importantly, the 
manual lists the actual standards, distinguishing between basic and expert level standards. The 
present document does not contain the actual standards — it provides only a summary of the basic 
standards. In addition, the manual contains a detailed introduction, further information on how to use 
the standards, a comprehensive glossary, as well as the list of original documents upon which the 
standards are based. This information is necessary for a good understanding of the context and 
meaning of the standards.  
 
Where possible, users of the quick guide should consult the full manual to obtain a better 
understanding of the standards. Additional materials are also available electronically on the 
EMCDDA website and the project website (see links in box on page 5). 
 
Due to the limited detail provided in this document and its focus on general information and initial self-
reflection, the quick guide is less suitable for other purposes (e.g. development of quality criteria). 
Professionals interested in using the standards for such purposes should refer to the full manual only. 
 
In the next part of the guide, all project stages and components of the standards are briefly 
introduced, highlighting why they are important and beneficial to prevention professionals and target 
populations. The basic standards are summarised in the form of self-reflection checklists, which also 
provide users with a dedicated space to reflect on their work in relation to each component. The 
tables in the checklists consist of five columns: summary of the basic standards; three checkboxes to 
determine the extent to which the standards are currently met; a checkbox ‘Not applicable’; a space 
for making notes on the current position; and a space for recording necessary follow-up actions. At 
the end of the quick guide, a summary page encourages readers to record the main findings and 
actions emerging from completing the checklists. 
 
The table ‘How to fill in the checklists’ shows the sections of the checklists and how they can be 
completed. 
 
The purpose of the checklists is to facilitate initial self-reflection, i.e. to determine one’s own position 
in relation to the standards and to identify areas for improvement. The precise nature of this exercise 
will depend on the particular circumstances of the programme or organisation (‘What do I/we want to 
achieve?’) and on what is realistic (‘What can I/we actually achieve?’). In the manual, some standards 
contain examples of how achievement can be evidenced in practice; this can help professionals judge 
whether standards are met. The follow-up project being implemented from April 2013 to March 2015 
will also provide specific indicators for evidencing achievement of the standards. Sources of evidence 
may include written evidence, for example the project plan or descriptions of the organisation (e.g. on 
the company/service website), direct observations of work procedures or programme implementation, 
or conversations with staff members, participants, and/or other stakeholders. However, the checklists 
do not require users of this document to formally evidence achievement of the standards. 
Professionals interested in conducting formal self-assessment using the standards will benefit from 
the toolkits which are being developed as part of the follow-up project (www.prevention-standards.eu). 
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Notes on current position Actions to take 
This section contains the 
titles of the components and 
summarises the basic 
standards contained within 
each component. While 
considering each component, 
users should consult the full 
version of the standards to 
find out about the relating 
basic and expert standards in 
detail. This will help them to 
reflect on and determine their 
position. 
This part of the checklist 
enables users to rate their 
work (e.g. professional 
development, activity, 
organisation, strategy, etc.) in 
relation to the standards by 
ticking the category ‘Not met’, 
‘Partially met’, or ‘Fully met’. 
Positioning their own work 
along this scale will help 
professionals to identify areas 
for improvement and to track 
progress over time. Generally 
speaking, the category ‘Not 
met’ should be chosen if 
none or very few standards 
are met, the category 
‘Partially met’ should be 
chosen if all or most basic 
standards are met, and the 
category ‘Fully met’ should be 
ticked if all basic and all or 
most expert standards are 
met, although this will also 
depend on the particular 
circumstances of the 
programme or organisation. 
The option ‘Not applicable’ 
should only be ticked if 
required and after thorough 
consideration of the 
standards’ relevance. Users 
should beware of choosing 
this option too easily, 
acknowledging instead that 
perhaps the standard is 
applicable but not currently 
feasible. If choosing the 
option ‘Not applicable’, a brief 
comment in the column 
‘Notes on current position’ 
should be provided, clarifying 
why the component was not 
(currently) considered 
applicable.  
 
This column allows users to 
comment on their rating. It 
gives an opportunity to 
describe what standards 
have been achieved already 
and to provide the evidence 
to support the rating (by 
referring to tangible pieces of 
evidence where possible). 
This is a chance to make 
explicit the good work that is 
already being done. Users 
should also use this space to 
point out weaknesses and 
areas for improvement (e.g. 
what standards have not yet 
been met and why). 
Actions and changes required 
to improve current efforts 
should be outlined in this 
column. This could include, 
for example, the need to 
review the project plan or the 
need for additional staff 
training. Actions and changes 
should be realistic in order to 
make the reflection practically 
relevant: ‘What actions and 
changes can I/we take now 
(or in the foreseeable future) 
to improve my/our drug 
prevention efforts?’. 
However, it may also be 
useful to note long-term 
actions and aims that can be 
tackled at a later point in time 
(e.g. following the next 
review). In order to make 
actions more specific, it can 
be helpful to think about and 
note: when these changes 
will happen; who will be 
involved; and what resources 
will be required. 
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The standards and checklists 
 
Cross-cutting considerations 
 
There are many recurring themes that do not concern only one project stage, but the entire project 
cycle. For the purposes of these standards, four of these themes have been placed in the middle of 
the project cycle as they should be reconsidered at each project stage.  
 
A: Sustainability and funding 
Programmes should be seen as embedded in a wider framework of drug prevention activities. The 
long-term viability of prevention work should be ensured as far as possible. Ideally, programmes can 
continue beyond their initial implementation and/or after external funding has stopped. However, 
sustainability depends not only upon the continued availability of funding but also upon the lasting 
commitment of staff and other relevant stakeholders to the organisation and/or the field of drug 
prevention. The standards in this component outline how sustainability can be ensured by ‘anchoring’ 
programmes within existing systems and by developing strategies to secure necessary resources, 
particularly funding. 
 
B: Communication and stakeholder involvement 
Stakeholders are individuals, groups and organisations that have a vested interest in the activities and 
outcomes of the programme, and/or who are directly or indirectly affected by it, such as the target 
population, the community, funders, and other organisations working in the field of drug prevention. 
Relevant stakeholders should be contacted and involved in the programme as necessary. The 
support and cooperation of the target population will be a requirement for any programme. Other 
forms of stakeholder involvement may include establishing links with community ‘leaders’ or the local 
media who subsequently support the programme and increase its visibility. Involving other 
organisations working in the field is useful to coordinate efforts, share lessons learnt, and establish 
joint planning and budgeting. A communications strategy enables exchange between the various 
groups involved in the programme. 
 
C: Staff development 
This component consists of three pillars: staff training; further development; and professional and 
emotional support. Staff training needs should be assessed before implementation, and staff 
members should be trained to ensure that the programme is delivered to a high standard. Although 
professional competencies as such are not a focus of the standards, the standards can facilitate the 
development of training plans by outlining the types of professional competencies that staff members 
should have (
5
). Continuous staff development is a means of rewarding and retaining staff members 
and ensuring that their knowledge and skills are up-to-date. During the implementation of the 
programme, it is important to give staff members the opportunity to reflect on their work and to 
improve on the job.  
 
D: Ethical drug prevention 
Drug prevention activities may not require physical or clinical intervention, but they represent a form of 
intervention in people’s lives nevertheless. Moreover, prevention is typically targeted at young people, 
and in the case of selective and indicated prevention these young people can be among the most 
vulnerable in society. Professionals should not assume that drug prevention activities are per 
definition ethical and beneficial for participants. The standards outline principles of ethical drug 
prevention which focus on: the providers’ lawful conduct; respect for participants’ rights and 
autonomy; real benefits for participants; no harms for participants; providing truthful information; 
obtaining consent; voluntary participation; ensuring confidentiality; tailoring the intervention to 
participants’ needs; involving participants as partners; and health and safety. While it may not always 
be possible to adhere to all principles of ethical drug prevention, an ethical approach must be clearly 
evident at every project stage. Consequently, protocols are developed to protect participants’ rights, 
and potential risks are assessed and mitigated. 
                                                     
(
5
) For an example resource dedicated to this topic see the ‘Competencies for Canada's Substance Abuse Workforce’ 
developed by the Canadian Centre on Substance Abuse (CCSA), available at 
www.ccsa.ca/eng/priorities/workforce/competencies/  
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Notes on current position 
 
Actions to take 
 
A: Sustainability and funding: The 
programme promotes a long-term view on drug 
prevention and is not a fragmented short-term 
initiative. The programme is coherent in its 
logic and practical approach. The programme 
seeks funding from different sources. 
    
  
B: Communication and stakeholder 
involvement: The multi-service nature of drug 
prevention is considered. All stakeholders 
relevant to the programme (e.g. target 
population, other agencies) are identified, and 
they are involved as required for a successful 
programme implementation. The organisation 
cooperates with other agencies and 
institutions. 
    
  
  
European drug prevention quality standards: a quick guide 
 
Please refer to the full list of basic and expert standards in the EMCDDA manual when conducting your self-reflection, see 
http://www.emcdda.europa.eu/publications/manuals/prevention-standards 13 
 
Cross-cutting considerations (cont.) 
Basic standards (summary): 
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Notes on current position 
 
Actions to take 
 
C: Staff development: It is ensured prior to 
the implementation that staff members have 
the competencies which are required for a 
successful programme implementation. If 
necessary, high quality training based on a 
training needs analysis is provided. During 
implementation, staff members are supported 
in their work as appropriate. 
    
  
D: Ethical drug prevention: A code of ethics 
is defined. Participants’ rights are protected. 
The programme has clear benefits for 
participants, and will not cause them any harm. 
Participant data is treated confidentially. The 
physical safety of participants and staff 
members is protected. 
    
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Project stage 1: Needs assessment 
 
Before the intervention can be planned in detail, it is important to explore the nature and extent of 
drug-related needs, as well as possible causes and contributing factors to those needs. This ensures 
that the intervention is necessary, and that it will address the correct needs and target population(s). 
Four types of needs are distinguished: policy needs; (general) community needs; needs defined by 
gaps in the provision of prevention; and (specific) target population needs. 
 
1.1 Knowing drug-related policy and legislation: Drug-related policy and legislation should guide 
all drug prevention activities. The team must be aware of and work in correspondence with drug-
related policy and legislation at the local, regional, national, and/or international level. Where 
programmes address needs that are not current policy priorities, programmes should still support the 
wider drug prevention agenda as defined by national or international strategies. Other guidance, such 
as binding standards and guidelines, should also be considered where appropriate. 
 
1.2 Assessing drug use and community needs: The second component in this project stage 
specifies the requirement to assess the drug situation in the general population or specific 
subpopulations. It is not sufficient to rely on assumptions or ideology when planning prevention work. 
Instead, drug prevention programmes must be informed by an empirical assessment of people’s 
needs. The assessment can utilise quantitative and/or qualitative methods, and should draw upon 
existing (epidemiological) data where relevant data of high quality is already available (e.g. from 
national drugs observatories). Other relevant issues, such as deprivation and inequalities, should also 
be assessed to account for the relationship between drug use and other needs. One needs 
assessment may inform several different activities across a defined time span, although it is important 
to ensure that the data is up-to-date. Regional drugs coordination teams can have an important role to 
play in the achievement of these standards. 
 
1.3 Describing the need — Justifying the intervention: The findings from the community needs 
assessment are documented and contextualised to justify the need for the intervention. The 
justification should take into account the views of the community to ensure that the programme is 
relevant to them. A focus on ‘needs’ rather than ‘problems’ can help engage stakeholders who may 
otherwise feel stigmatised. Existing drug prevention programmes are also analysed at this point to 
gain an understanding of how the programme can complement the current structure of provision. 
 
1.4 Understanding the target population: The needs assessment is then taken further by gathering 
detailed data on the prospective target population, such as information about risk and protective 
factors, and the target population’s culture and everyday life. A good understanding of the target 
population and its realities is a prerequisite for effective, cost-effective and ethical drug prevention. 
Where appropriate, the intermediate target population which will receive the intervention but is not in 
itself at risk of drug use (e.g., parents, teachers) may need to be considered in addition to the ultimate 
target population (e.g., young people at risk of drug use). 
 
This stage may be conducted at the same time as, or after, the resource assessment. 
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Notes on current position  
 
Actions to take 
 
1.1 Knowing drug-related policy and 
legislation: The knowledge of drug-related 
policy and legislation is sufficient for the 
implementation of the programme. The 
programme supports the objectives of local, 
regional, national, and/or international 
priorities, strategies, and policies. 
    
  
1.2 Assessing drug use and community 
needs: The needs of the community (or 
environment in which the programme will be 
delivered) are assessed. Detailed and diverse 
information on drug use is gathered. The study 
utilises existing epidemiological knowledge as 
possible, and adheres to principles of ethical 
research. 
    
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1.  Needs assessment (cont.) 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
1.3 Describing the need — Justifying the 
intervention: The need for an intervention is 
justified. The main needs are described based 
on the needs assessment, and the potential 
future development of the situation without an 
intervention is indicated. Gaps in current 
service provision are identified. 
    
  
1.4 Understanding the target population: A 
potential target population is chosen in line with 
the needs assessment. The needs assessment 
considers the target population’s culture and its 
perspectives on drug use. 
    
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Project stage 2: Resource assessment 
 
A programme is not only defined by target population needs, but also by available resources. While 
the needs assessment (see 1: Needs assessment) indicates what the programme should aim to 
achieve, the resource assessment provides important information on whether and how these aims 
can be achieved. Thus, resources must be assessed to gain a realistic understanding of the desirable 
type and possible scope of the programme. 
 
2.1 Assessing target population and community resources: Drug prevention programmes can 
only be successful if the target population, community and other relevant stakeholders are ‘ready’ to 
engage, e.g. able and willing to take part or support implementation. They may also have resources 
that can be utilised as part of the programme (e.g. networks, skills). The standards in this component 
describe the requirement to assess and consider potential sources of opposition to and support for 
the programme, as well as available resources of relevant stakeholders. 
 
2.2 Assessing internal capacities: The analysis of internal resources and capacities is important, as 
the programme will only be feasible if it is in line with available staff, financial, and other resources. 
This step is carried out before programme formulation to gain an understanding of what types of 
programmes might be feasible. As the purpose of the assessment is to inform programme planning, it 
does not have to be a ‘formal’ assessment carried out by an external organisation but could, for 
example, consist of an informal discussion between staff members to identify organisational strengths 
and weaknesses in terms of resources. 
 
This stage may be conducted at the same time as the needs assessment, or at the beginning of the 
project before the needs assessment. 
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2 . Resource assessment 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
2.1 Assessing target population and 
community resources: Sources of opposition 
to, and support of, the programme are 
considered, as well as ways of increasing the 
level of support. The ability of the target 
population and other relevant stakeholders to 
participate in the programme is assessed. 
    
  
2.2 Assessing internal capacities: Internal 
resources and capacities are assessed (e.g. 
human, technological, financial resources). The 
assessment takes into account their current 
availability as well as their likely future 
availability for the programme. 
    
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Project stage 3: Programme formulation 
 
The programme formulation outlines the programme content and structure, and it provides the 
necessary foundation to allow targeted, detailed, coherent, and realistic planning. Based on the 
assessment of target population needs and available resources, the programme’s core elements 
should be clearly defined. These standards aim to stimulate a change in professional culture towards 
a more systematic and evidence-based approach to drug prevention work.  
 
3.1 Defining the target population: A good definition of the target population ensures that the 
intervention is targeted at the right people. The target population may consist of individuals, groups, 
households, organisations, communities, settings, and/or other units, as long as they are identifiable 
and clearly defined. Some programmes may need to distinguish the ultimate target population (e.g. 
young people at risk of drug use) from the intermediate target population (e.g. parents, teachers, 
peers of these young people). The definition should be specific and appropriate for the scope of the 
programme. For example, an important consideration is whether the target population can be reached 
within the realities of the programme. 
 
3.2 Using a theoretical model: A theoretical model is a set of interrelated assumptions explaining 
how and why an intervention is likely to produce outcomes in the target population. Using a theoretical 
model that is suitable for the particular context of the programme increases the likelihood that the 
programme will successfully achieve its objectives. It helps identify relevant mediators of drug-related 
behaviours (such as intentions and beliefs that influence drug use) and determine feasible goals and 
objectives. All interventions should be based on sound theoretical models, particularly if they are 
newly developed.  
 
3.3 Defining aims, goals, and objectives: Without clear aims, goals, and objectives, there is a 
serious risk of conducting drug prevention work for its own sake, instead of for the benefit of the target 
population. The standards use a three-level structure of interconnected aims, goals, and objectives. 
Aims describe the programme’s long-term direction, general idea, purpose, or intention. They may or 
may not be achievable within the specific intervention but provide a strategic direction for activities. 
Goals are clear statements on the programme’s outcome for participants (in terms of behaviour 
change) at the completion of the intervention. Objectives describe the immediate or intermediate 
behaviour change in participants that is necessary to achieve a final goal. Finally, operational 
objectives describe the activities that are required to achieve goals and objectives. 
 
Page 120 of the manual in English contains a figure illustrating the connection between aims, goals 
and objectives, and provides further information on the difference between specific objectives 
(focussing on behaviour change) and operational objectives (focussing on activities). 
 
3.4 Defining the setting: The setting is the social and/or physical environment in which the 
intervention takes place, such as family, school, workplace, nightclub, community, or society. The 
needs assessment may show that one or more settings are relevant; however, practical 
considerations (e.g. ease of access, necessary collaborations) must also be taken into account when 
deciding on the setting. A clear definition of the setting is essential so that others may understand 
where, and how, the intervention was delivered.  
 
3.5 Referring to evidence of effectiveness: When planning drug prevention work, it is important to 
be aware and make use of existing knowledge on ‘what works’ in drug prevention. The existing 
scientific evidence base on effective drug prevention should be consulted, and the findings relevant to 
the programme highlighted. The scientific evidence must be integrated with the professional 
experience of practitioners to design an intervention that is relevant to the specific programme 
context. Where scientific evidence of effectiveness is not available, professional experiences and 
stakeholder expertise may be described instead. However, the limitations of these forms of 
knowledge compared to robust research evidence should be carefully considered (e.g. 
generalisability). 
 
3.6 Determining the timeline: A realistic timeline is essential in the planning and implementation of 
the programme so that staff members can target and coordinate their efforts. It illustrates the planned 
schedule of activities and applicable deadlines. The timeline may be updated during the 
implementation of the programme to reflect its actual development. 
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Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
3.1 Defining the target population: The 
target population(s) of the programme is (are) 
described. The chosen target population(s) can 
be reached. 
    
  
3.2 Using a theoretical model: The 
programme is based on an evidence-based 
theoretical model that allows an understanding 
of the specific drug-related needs and shows 
how the behaviour of the target population can 
be changed. 
    
  
3.3 Defining aims, goals, and objectives: It 
is clear what is being ‘prevented’ (e.g. what 
types of drug use?). The programme’s aims, 
goals, and objectives are clear, logically linked, 
and informed by the identified needs. They are 
ethical and ‘useful’ for the target population. 
Goals and objectives are specific and realistic. 
    
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3. Programme formulation (cont.) 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
3.4 Defining the setting: The setting(s) for the 
activities is (are) described. It matches the 
aims, goals, and objectives, available 
resources, and is likely to produce the desired 
change. Necessary collaborations for 
implementation of the programme in this 
setting are identified. 
    
  
3.5 Referring to evidence of effectiveness: 
Scientific literature reviews and/or essential 
publications on the issues relating to the 
programme are consulted. The reviewed 
information is of high quality and relevant to the 
programme. The main findings are used to 
inform the programme.  
    
  
3.6 Determining the timeline: The timeline of 
the programme is realistic, and it is illustrated 
clearly and coherently. Timing, duration, and 
frequency of activities are adequate for the 
programme. 
    
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Project stage 4: Intervention design 
 
The content of interventions is usually covered in guidelines rather than quality standards, as it is 
specific to the needs of the target population, the aims of the programme, etc. However, there are 
some formal aspects that can be generalised. These standards assist in the development of a new 
intervention as well as in the selection and adaptation of an existing intervention. The standards also 
encourage the consideration of evaluation requirements as part of the intervention design. 
 
4.1 Designing for quality and effectiveness: After the cornerstones of the intervention have been 
outlined, its details are specified. Planning evidence-based activities that participants are likely to 
experience as engaging, interesting and meaningful is an important aspect of achieving the set goals 
and objectives. Where possible, the intervention should be designed as a logical progression of 
activities that reflects participants’ development throughout the intervention. Consulting a variety of 
sources on previously implemented programmes can help avoid pursuing activities that have already 
been shown to be ineffective or to have iatrogenic effects. 
 
The United Nations Office on Drugs and Crime (UNODC) has published International Standards on 
Drug Use Prevention. The standards describe interventions and policies that have been found to 
produce positive drug prevention outcomes in children, adolescents and adults. They can be found at: 
http://www.unodc.org/unodc/en/prevention/prevention-standards.html  
 
4.2 If selecting an existing intervention: Before developing a new intervention, it should be 
considered whether an appropriate intervention might already exist, either in practice or in manualised 
form. Several factors need to be considered in the selection of an existing intervention, including 
whether it is relevant to the particular circumstances of the programme and (in the case of 
programmes not free of charge) whether it is affordable. The intervention is then adapted to match the 
specific situation of the programme. Adaptation consists of careful intentional and planned changes 
made to the original intervention before implementation to ensure that it is appropriate for the 
particular circumstances of the programme (e.g. target population needs) and to maintain or increase 
its effectiveness. 
 
4.3 Tailoring the intervention to the target population: Regardless of whether a new intervention is 
developed or an existing intervention adapted, the intervention must be tailored to the target 
population in line with the findings from the needs assessment. An essential staff competency in this 
regard is cultural sensitivity, i.e. the willingness and ability of staff members to understand the 
importance of (different types of) culture, to appreciate cultural diversity, to respond effectively to 
culturally defined needs, and to incorporate cultural considerations into all aspects of drug prevention 
work. If an existing intervention is used, tailoring may be conducted as part of the adaptation process. 
Additionally, flexibility should be built into the intervention design, allowing practitioners to tailor the 
intervention during implementation without having to deviate from the original plan. 
 
4.4 If planning final evaluations: Monitoring and final process and outcome evaluations should also 
be planned at this stage. Outcome evaluation is a means to assessing whether goals and objectives 
were achieved, whereas process evaluation is a means of understanding how they were achieved or, 
in some cases, not achieved. An evaluation team should decide upon the appropriate type of 
evaluation for the programme, and define evaluation indicators in line with goals and objectives. It 
should be clarified what data will be collected, and how it will be collected (e.g. specification of 
timeline and data collection tools). Where an outcome evaluation is planned, the research design 
should be determined. Considering evaluation at this stage ensures that the data required for 
monitoring and final evaluations will be available in a satisfactory form when it is needed. 
 
The manual provides further detail on process and outcome evaluations, data collection 
considerations and how to formulate evaluation indicators and benchmarks based on the specified 
goals and objectives. See also the standards in project stage 7: Final evaluations. 
 
This stage may be conducted at the same time as the management and mobilisation of resources. 
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4. Intervention design 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
4.1 Designing for quality and effectiveness: 
The intervention follows evidence-based good 
practice recommendations; the scientific 
approach is outlined. The programme builds on 
positive relationships with participants by 
acknowledging their experiences and 
respecting diversity. Programme completion is 
defined. 
    
  
4.2 If selecting an existing intervention: 
Benefits and disadvantages of existing 
interventions are considered, as well as the 
balance between adaptation, fidelity, and 
feasibility. The intervention’s fit to local 
circumstances is assessed. The chosen 
intervention is adapted carefully, and changes 
are made explicit. Authors of the intervention 
are acknowledged. 
    
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4. Intervention design (cont.) 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
4.3 Tailoring the intervention to the target 
population: The programme is adequate for 
the specific circumstances of the programme 
(e.g. target population characteristics), and 
tailored to those if required. Elements to tailor 
include; language, activities, messages, timing, 
number of participants. 
    
  
4.4 If planning final evaluations: Evaluation 
is seen as an integral and important element to 
ensuring programme quality. It is determined 
what kind of evaluation is most appropriate for 
the intervention, and a feasible and useful 
evaluation is planned. Relevant evaluation 
indicators are specified, and the data collection 
process is described. 
    
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Project stage 5: Management and mobilisation of resources 
 
A drug prevention programme consists not only of the actual intervention, but also requires good 
project management and detailed planning to ensure that it is feasible. Managerial, organisational, 
and practical aspects need to be considered alongside the intervention design. To start 
implementation, available resources must be activated and new resources accessed as necessary. 
Project management reference books provide in-depth information on how to plan and manage 
projects. However, together with project stage 3: Programme formulation these standards highlight 
some of the main considerations in relation to drug prevention work. 
 
5.1 Planning the programme — Illustrating the project plan: A dedicated procedure ensures that 
planning and implementation are conducted systematically. A written project plan documents all tasks 
and procedures that are required for the successful implementation of the programme. The project 
plan guides implementation by providing a common framework that all staff members can work 
towards. In later project stages, the project plan is consulted to assess whether the programme is 
implemented as intended, and if any adjustments are required. 
 
The project plan should also illustrate and connect the main components of the programme, such as 
target population needs, goals and objectives, the theoretical model, evaluation indicators and 
benchmarks, activities and outcomes. This can be done using a logic model. The EMCDDA's 
Prevention and Evaluation Resources Kit (PERK) includes many examples of how to formulate and 
use logic models; accessible from: http://www.emcdda.europa.eu/publications/perk  
 
5.2 Planning financial requirements: The financial requirements (costs) and capacities (budget) of 
the programme must be determined to put necessary and available resources into context. The costs 
must not exceed the budget that is (or will be available) for the programme. If more resources are 
required than are available, the financial plan clarifies what additional funding might be required or 
how the project plan may need to be altered. 
 
5.3 Setting up the team: The team consists of the people working on the programme (e.g. 
managing, delivering, evaluating the programme). Staff members (including volunteers) should be 
chosen in correspondence with legal requirements and the needs of the programme. Roles and 
responsibilities should be distributed accordingly, guaranteeing that all necessary tasks have been 
assigned and are carried out by the most suitable persons (i.e. those with suitable qualifications 
and/or experience). This component should be seen in conjunction with component C: Staff 
development. 
 
5.4 Recruiting and retaining participants: Recruitment refers to the process of choosing eligible 
individuals from the target population, informing them about the programme, inviting them to take part, 
enrolling them, and ensuring that they begin the intervention (e.g., attend the first session). 
Participants should be recruited from the defined target population in a methodologically correct and 
ethical way. Retention refers to the process of ensuring that all participants remain in the intervention 
until it has finished and/or until the goals have been achieved (whichever is more appropriate). This is 
particularly relevant for programmes that need to engage participants over long periods of time. 
Barriers to participation should be identified and removed to ensure that participants can take part in 
and complete the programme. 
 
5.5 Preparing programme materials: The materials that are required for implementation of the 
programme should be considered, including intervention materials (where appropriate), instruments 
for monitoring and evaluation, technical equipment, the physical environment (e.g. facilities), etc. This 
allows finalising the financial plan, and taking action to secure necessary materials. If intervention 
materials are used (e.g. manuals, films, websites), they should be of high quality and suitable for the 
intended users. 
 
5.6 Providing a programme description: A written programme description provides a clear overview 
of the programme. It is produced so that interested stakeholders (e.g. target population, funders, other 
interested professionals) may obtain information about the programme before its start and/or while it 
is ongoing. The intervention and its activities should be described in detail, although the level of detail 
will depend upon the scope of the programme and the likely readers of the description. If the 
description is used in participant recruitment, particular emphasis must be put on the potential risks 
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and benefits for participants. The programme description differs from the project plan (which is an 
internal tool to guide programme implementation) and from the final report (which summarises the 
programme once it has finished). 
 
This stage may be conducted at the same time as the intervention design. 
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5. Management and mobilisation of resources 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
5.1 Planning the programme — Illustrating 
the project plan: Time is set aside for 
systematic programme planning. A written 
project plan outlines the main programme 
elements and procedures. Contingency plans 
are developed. 
    
  
5.2 Planning financial requirements: A clear 
and realistic cost estimate for the programme 
is given. The available budget is specified and 
adequate for the programme. Costs and 
available budget are linked. Financial 
management corresponds to legal 
requirements. 
    
  
5.3 Setting up the team: The staff required for 
successful implementation is defined and 
(likely to be) available (e.g. type of roles, 
number of staff). The set-up of the team is 
appropriate for the programme. Staff selection 
and management procedures are defined. 
    
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5.  Management and mobilisation of resources (cont.) 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
5.4 Recruiting and retaining participants: It 
is clear how participants are drawn from the 
target population, and what mechanisms are 
used for recruitment. Specific measures are 
taken to maximise recruitment and retention of 
participants. 
    
  
5.5 Preparing programme materials: 
Materials necessary for implementation of the 
programme are specified. If intervention 
materials (e.g. manuals) are used, the 
information provided therein is factual and of 
high quality. 
    
  
5.6 Providing a programme description: A 
written, clear programme description exists and 
is (at least partly) accessible by relevant 
groups (e.g. participants). It outlines major 
elements of the programme, particularly its 
possible impact on participants. 
    
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Project stage 6: Delivery and monitoring 
 
At this stage, the plans developed earlier are put into practice. A particular issue at this point is the 
need to maintain a balance between fidelity (i.e. adhering to the project plan) and flexibility (i.e. 
responding to emerging new developments). The components outline how this balance can be 
achieved by questioning the quality and progress of the implementation, and making controlled 
modifications to improve the programme. 
 
6.1 If conducting a pilot intervention: In certain cases, for example if an intervention is newly 
developed or is to be rolled out from local to national implementation, the intervention should be 
tested first by implementing it on a smaller scale. This helps identify potential practical issues and 
other weaknesses that did not emerge during the planning, and which may be very costly to address 
once implementation is fully underway. A pilot intervention (or pilot study) is a small-scale trial of the 
intervention prior to its full implementation (e.g., with fewer participants, in only one or two locations). 
During the pilot intervention, process and (limited) outcome data are collected and used to perform a 
small-scale evaluation. Using the findings from the pilot, programme developers can make final and 
inexpensive adjustments to the intervention before the actual implementation. 
 
6.2 Implementing the intervention: Once there is sufficient evidence to suggest that the intended 
drug prevention intervention will be effective, feasible, and ethical, the intervention is implemented as 
outlined in the project plan. However, this does not mean that the project plan must be strictly 
adhered to if there is an obvious need for modifications. To facilitate later evaluations and reporting on 
the programme, the implementation is documented in detail, including unexpected events, deviations, 
and failures. 
 
6.3 Monitoring the implementation: While the programme is carried out, outcome and process data 
are collected and analysed periodically, for example with regard to the relevance of the intervention to 
participants, fidelity to the project plan, and effectiveness. Actual implementation of the intervention 
and other programme aspects is compared to what was set out in the project plan. Regular reviews of 
the progress also help identify if there is a need for modifying the original plan. Monitoring ensures 
that implementation is of high quality, but it also allows providers to improve prevention practice by 
identifying and responding to changed or additional requirements before these pose a threat to the 
success of the programme. 
 
6.4 Adjusting the implementation: Implementation needs to remain flexible so that it can respond to 
emerging problems, changed priorities, etc. Where necessary and possible, implementation of the 
programme should be adjusted in line with the findings from the monitoring review. However, 
modifications must be minimal and well justified, and their potential negative impact on the 
programme must be considered. Consequently, if adjustments are made, they must be documented 
and evaluated to understand what effect they had on participants and the success of the programme. 
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6. Delivery and monitoring 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
6.1 If conducting a pilot intervention: A pilot 
intervention is conducted if necessary. It 
should be considered, for example, when 
implementing new or strongly adapted 
interventions, or if programmes are intended 
for wide dissemination. The findings from the 
pilot evaluation are used to inform and improve 
the proper implementation of the intervention. 
    
  
6.2 Implementing the programme: The 
programme is implemented according to the 
written project plan. The implementation is 
adequately documented, including details on 
failures and deviations from the original plan. 
    
  
  
European drug prevention quality standards: a quick guide 
 
Please refer to the full list of basic and expert standards in the EMCDDA manual when conducting your self-reflection, see: 
http://www.emcdda.europa.eu/publications/manuals/prevention-standards 31 
 
6. Delivery and monitoring (cont.) 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
6.3 Monitoring the implementation: 
Monitoring is seen as an integral part of the 
implementation phase. Outcome and process 
data are collected during implementation and 
reviewed systematically. The project plan, 
resources, etc. are also reviewed. The purpose 
of monitoring is to determine if the programme 
will be successful and to identify any necessary 
adjustments.  
    
  
6.4 Adjusting the implementation: Flexibility 
is possible if required for a successful 
implementation. The implementation is 
adjusted in line with the monitoring findings, 
where possible. Issues and problems are dealt 
with in a manner that is appropriate for the 
programme. Adjustments are well-justified, and 
reasons for adjustments are documented. 
    
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Project stage 7: Final evaluations 
 
After the intervention has been completed, final evaluations assess its outcomes and/or the process 
of delivering the intervention and implementing the programme. Briefly, outcome evaluations focus on 
the behaviour change in participants (e.g. reduced drug use), whereas process evaluations focus on 
the outputs of the activity (e.g. number of sessions delivered, number of participants contacted). The 
standards in this project stage must be seen in relation to component 4.4 If planning final evaluations, 
which also highlights what preparations are necessary to ensure that relevant data is collected during 
implementation. 
 
Under component 4.4 If planning final evaluations, the manual contains a brief introduction to process 
and outcome evaluation as conceptualised in the standards, and illustrates how specific aims, goals 
and objectives can be formulated and translated into evaluation indicators and benchmarks. 
 
The EMCDDA has also published Guidelines for the evaluation of drug prevention (updated in 2012), 
which contain helpful examples of how to plan and report the different aspects of evaluation. They can 
be found at http://www.emcdda.europa.eu/publications/manuals/prevention_update  
 
7.1 If conducting an outcome evaluation: As part of the outcome evaluation, outcome data is 
systematically collected and analysed to assess how effective the intervention was. All outcomes 
should be reported as defined in the planning phase (i.e. in line with the defined evaluation 
indicators). Depending on the scale of the programme and the research design that was employed, 
statistical analyses should be performed to determine the effectiveness of the intervention in 
achieving the defined goals. Where possible, a causal statement on the intervention’s effectiveness 
summarises the findings of the outcome evaluation. 
 
7.2 If conducting a process evaluation: The process evaluation documents what happened during 
the implementation of the programme. Moreover, it analyses the quality and usefulness of the 
programme by considering its reach and coverage, acceptance of the intervention by participants, 
implementation fidelity, and use of resources. The findings from the process evaluation help to explain 
the findings from the outcome evaluation and to understand how the programme can be improved in 
the future. 
  
The findings from the outcome evaluation and the process evaluation must be interpreted together in 
order to gain a thorough understanding of the success of the programme. This knowledge will inform 
the final project stage 8. Dissemination and improvement. 
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7. Final evaluations 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
7.1 If conducting an outcome evaluation: 
The sample size on which the outcome 
evaluation is based is given, and it is 
appropriate for the data analysis. An 
appropriate data analysis is conducted, 
including all participants. All findings are 
reported in measurable terms. Possible 
sources of bias and alternative explanations for 
findings are considered. The success of the 
programme is assessed. 
    
  
7.2 If conducting a process evaluation: The 
implementation of the programme is 
documented and explained. The following 
aspects are evaluated: target population 
involvement; activities; programme delivery; 
use of financial, human, and material 
resources. 
    
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Project stage 8. Dissemination and improvement 
 
In the final project stage, the future of the programme is of major concern: should the programme 
continue, and if so, how? Disseminating information about the programme can help to promote its 
continuation, but it also enables others to learn from the experiences of implementing the programme. 
 
8.1 Determining whether the programme should be sustained: Ideally, a high quality drug 
prevention programme can continue beyond its initial implementation and/or after external funding 
has stopped. Using the empirical evidence produced through monitoring and final evaluations 
(depending on what data is available), it is possible to decide whether the programme is worthy of 
continuation. If it is determined that the programme should be sustained, appropriate steps and 
follow-up actions should be specified and carried out. 
 
8.2 Disseminating information about the programme: Dissemination can benefit the programme in 
many ways, for example by gaining support from relevant stakeholders for its continuation or by 
improving the programme through feedback. It also adds to the evidence base for drug prevention, 
thus contributing to future drug policy, practice and research. In order to give other providers the 
opportunity to replicate the intervention, intervention materials and other relevant information (e.g. 
costing information) should also be made available in as much detail as possible (depending on 
copyright requirements etc.). 
 
8.3 If producing a final report: The final report is an example of a dissemination product. It may be 
produced as a record of the implementation, as part of a funding agreement, or simply to inform 
others about the programme. The final report will often represent a summary of the documentation 
produced during earlier project stages. It describes the scope and activities of the programme, and, 
where available, the findings from the final evaluations. As a final report is not always required and 
other means of dissemination may be more appropriate (e.g., oral presentations), this component is 
only relevant if a final report is produced. 
 
This stage may represent the beginning of a new project cycle aimed at improving and developing the 
existing programme further. 
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8. Dissemination and improvement 
Basic standards (summary): 
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Notes on current position  
 
Actions to take 
 
8.1 Determining whether the programme 
should be sustained: It is determined whether 
the programme should be continued based on 
the evidence provided by monitoring and/or 
final evaluations. If it is to be continued, 
opportunities for continuation are outlined. The 
lessons learnt from the implementation are 
used to inform future activities. 
    
  
8.2 Disseminating information about the 
programme: Information on the programme is 
disseminated to relevant target audiences in an 
appropriate format. To assist replication, 
details on implementation experiences and 
unintended outcomes are included. Legal 
aspects of reporting on the programme are 
considered (e.g. copyright).  
    
  
8.3 If producing a final report: The final 
report documents all major elements of 
programme planning, implementation, and 
(where possible) evaluation in a clear, logical, 
and easy-to-read way. 
    
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Self-reflection: action plan 
 
This summary page provides an opportunity to summarise main findings from the self-reflection and 
major actions that should be taken to improve current activities. For future reference, it is important to 
note when the reflection took place and who was involved (this could be one person or, for example, 
the programme team). A date for the next review should also be specified, and marked in the office 
calendar. Although the standards should inform day-to-day practice, reflecting on and documenting 
achievement of the standards will usually be an infrequent and extraordinary activity. However, it is 
recommended to revisit the checklist at appropriate intervals to track progress and reinforce the 
motivation for improvement where necessary. 
 
Summary of main findings and actions emerging from the self-reflection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review date:  
Review undertaken by:  
Next review date:  
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Legal notice 
 
This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is 
protected by copyright. The EMCDDA accepts no responsibility or liability for any consequences 
arising from the use of the data contained in this document. The contents of this publication do not 
necessarily reflect the official opinions of the EMCDDA’s partners, the EU Member States or any 
institution or agency of the European Union. A great deal of extra information on the European Union 
is available on the Internet. It can be accessed through the Europa server (http://europa.eu). 
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